|
1
|
Filipski E and Lévi F: Circadian
disruption in experimental cancer processes. Integr Cancer Ther.
8:298–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alhopuro P, Bjorklund M, Sammalkorpi H,
Turunen M, Tuupanen S, Biström M, Niittymäki I, Lehtonen HJ,
Kivioja T, Launonen V, et al: Mutations in the circadian gene CLOCK
in colorectal cancer. Mol Cancer Res. 8:952–960. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dibner C, Schibler U and Albrecht U: The
mammalian circadian timing system: organization and coordination of
central and peripheral clocks. Annu Rev Physiol. 72:517–549. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wood PA, Yang X and Hrushesky WJ: Clock
genes and cancer. Integr Cancer Ther. 8:303–308. 2009. View Article : Google Scholar
|
|
5
|
Karantanos T, Theodoropoulos G, Gazouli M,
Vaiopoulou A, Karantanou C, Lymberi M and Pektasides D: Expression
of clock genes in patients with colorectal cancer. Int J Biol
Markers. 28:280–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Green C, Green CB, Douris N, Kojima S,
Strayer CA, Fogerty J, Lourim D, Keller SR and Besharse JC: Loss of
Nocturnin, a circadian deadenylase, confers resistance to hepatic
steatosis and diet-induced obesity. Proc Natl Acad Sci USA.
104:9888–9893. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lamont EW, James FO, Boivin DB and
Cermakian N: From circadian clock gene expression to pathologies.
Sleep Med. 8:547–556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Richards J and Gumz ML: Advances in
understanding the peripheral circadian clocks. FASEB J.
26:3602–3613. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu L and Lee CC: The circadian clock:
pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–361. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hunt T and Sassone-Corsi P: Riding tandem:
circadian clocks and the cell cycle. Cell. 129:461–464. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Green CB and Besharse JC: Identification
of a novel vertebrate circadian clock-regulated gene encoding the
protein nocturnin. Proc Natl Acad Sci USA. 93:14884–14888. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bozek K, Relógio A, Kielbasa SM, Heine M,
Dame C, Kramer A and Herzel H: Regulation of clock-controlled genes
in mammals. PLoS ONE. 4:e48822009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000: The global picture. Eur J Cancer. 37(Suppl
8): S4–S66. 2001.PubMed/NCBI
|
|
14
|
Heist RS, Sequist LV and Engelman JA:
Genetic changes in squamous cell lung cancer: a review. J Thorac
Oncol. 7:924–933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lahiri DK and Nurnberger JI Jr: A rapid
non-enzymatic method for the preparation of HMW DNA from blood for
RFLP studies. Nucleic Acids Res. 19:54441991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang X, Yan D, Teng M, Fan J, Zhou C, Li
D, Qiu G, Sun X, Li T, Xing T, et al: Reduced expression of PER3 is
associated with incidence and development of colon cancer. Ann Surg
Oncol. 19:3081–3088. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Climent J, Perez-Losada J, Quigley DA, Kim
IJ, Delrosario R, Jen KY, Bosch A, Lluch A, Mao JH and Balmain A:
Deletion of the PER3 gene on chromosome 1p36 in recurrent
ER-positive breast cancer. J Clin Oncol. 28:3770–3778. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zienolddiny S, Haugen A, Lie JA, Kjuus H,
Anmarkrud KH and Kjærheim K: Analysis of polymorphisms in the
circadian-related genes and breast cancer risk in the Norwegian
nurses working night shifts. Breast Cancer Res. 15:R532013.(Epub
ahead of print).
|
|
20
|
Zhu Y, Stevens RG, Hoffman AE, Fitzgerald
LM, Kwon EM, Ostrander EA, Davis S, Zheng T and Stanford JL:
Testing the circadian gene hypothesis in prostate cancer: a
population-based case-control study. Cancer Res. 69:9315–9322.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou F, He X, Liu H, Zhu Y, Jin T, Chen C,
Qu F, Li Y, Bao G, Chen Z and Xing J: Functional polymorphisms of
circadian positive feedback regulation genes and clinical outcome
of Chinese patients with resected colorectal cancer. Cancer.
118:937–946. 2012. View Article : Google Scholar
|
|
22
|
Zieker D, Jenne I, Koenigsrainer I,
Zdichavsky M, Nieselt K, Buck K, Zieker J, Beckert S, Glatzle J,
Spanagel R, et al: Circadian expression of clock- and tumor
suppressor genes in human oral mucosa. Cell Physiol Biochem.
26:155–166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang XL, Fu CJ and Bu RF: Role of
circadian clocks in the development and therapeutics of cancer. J
Int Med Res. 39:2061–2066. 2011. View Article : Google Scholar : PubMed/NCBI
|
